PL435967A1 - Zestaw biomarkerów miRNA do diagnostyki raka jajnika, sposób diagnostyki in vitro raka jajnika, zastosowania zestawu biomarkerów miRNA oraz test do diagnostyki in vitro raka jajnika - Google Patents
Zestaw biomarkerów miRNA do diagnostyki raka jajnika, sposób diagnostyki in vitro raka jajnika, zastosowania zestawu biomarkerów miRNA oraz test do diagnostyki in vitro raka jajnikaInfo
- Publication number
- PL435967A1 PL435967A1 PL435967A PL43596720A PL435967A1 PL 435967 A1 PL435967 A1 PL 435967A1 PL 435967 A PL435967 A PL 435967A PL 43596720 A PL43596720 A PL 43596720A PL 435967 A1 PL435967 A1 PL 435967A1
- Authority
- PL
- Poland
- Prior art keywords
- ovarian cancer
- diagnosis
- vitro
- mirna biomarkers
- diagnostic test
- Prior art date
Links
- 206010033128 Ovarian cancer Diseases 0.000 title abstract 12
- 206010061535 Ovarian neoplasm Diseases 0.000 title abstract 12
- 238000000338 in vitro Methods 0.000 title abstract 7
- 238000003745 diagnosis Methods 0.000 title abstract 5
- 239000000090 biomarker Substances 0.000 title abstract 4
- 108091070501 miRNA Proteins 0.000 title abstract 4
- 239000002679 microRNA Substances 0.000 title abstract 4
- 238000002405 diagnostic procedure Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 238000012544 monitoring process Methods 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Przedmiotem niniejszego wynalazku jest zestaw biomarkerów miRNA do diagnostyki in vitro raka jajnika, sposób diagnozowania in vitro raka jajnika, zastosowania zestawu biomarkerów miRNA do diagnozowania in vitro raka jajnika, w diagnostycznym badaniu przesiewowym in vitro pod kątem występowania raka jajnika, do oceny skuteczności leczenia raka jajnika, do monitorowania odpowiedzi na leczenie raka jajnika oraz do przewidywania wznowy raka jajnika po ukończonym leczeniu raka jajnika, jak również test do diagnostyki in vitro raka jajnika.
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18/252,634 US20240002949A1 (en) | 2020-11-12 | 2020-11-11 | Panel of mirna biomarkers for diagnosis of ovarian cancer, method for in vitro diagnosis of ovarian cancer, uses of panel of mirna biomarkers for in vitro diagnosis of ovarian cancer and test for in vitro diagnosis of ovarian cancer |
| PL435967A PL243444B1 (pl) | 2020-11-12 | 2020-11-12 | Diagnostyczny zestaw biomarkerów miRNA do diagnostyki raka jajnika, sposób diagnostyki in vitro raka jajnika, zastosowania takiego zestawu biomarkerów miRNA oraz zestaw testowy do diagnostyki in vitro raka jajnika |
| CA3198479A CA3198479A1 (en) | 2020-11-12 | 2021-11-11 | Panel of mirna biomarkers for diagnosis of ovarian cancer, method for in vitro diagnosis of ovarian cancer, uses of panel of mirna biomarkers for in vitro diagnosis of ovarian cancer and test for in vitro diagnosis of ovarian cancer |
| AU2021378868A AU2021378868A1 (en) | 2020-11-12 | 2021-11-11 | Panel of mirna biomarkers for diagnosis of ovarian cancer, method for in vitro diagnosis of ovarian cancer, uses of panel of mirna biomarkers for in vitro diagnosis of ovarian cancer and test for in vitro diagnosis of ovarian cancer |
| EP21840201.4A EP4244393A1 (en) | 2020-11-12 | 2021-11-11 | Panel of mirna biomarkers for diagnosis of ovarian cancer, method for in vitro diagnosis of ovarian cancer, uses of panel of mirna biomarkers for in vitro diagnosis of ovarian cancer and test for in vitro diagnosis of ovarian cancer |
| PCT/PL2021/050079 WO2022103287A1 (en) | 2020-11-12 | 2021-11-11 | Panel of mirna biomarkers for diagnosis of ovarian cancer, method for in vitro diagnosis of ovarian cancer, uses of panel of mirna biomarkers for in vitro diagnosis of ovarian cancer and test for in vitro diagnosis of ovarian cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL435967A PL243444B1 (pl) | 2020-11-12 | 2020-11-12 | Diagnostyczny zestaw biomarkerów miRNA do diagnostyki raka jajnika, sposób diagnostyki in vitro raka jajnika, zastosowania takiego zestawu biomarkerów miRNA oraz zestaw testowy do diagnostyki in vitro raka jajnika |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL435967A1 true PL435967A1 (pl) | 2022-05-16 |
| PL243444B1 PL243444B1 (pl) | 2023-08-28 |
Family
ID=79287850
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL435967A PL243444B1 (pl) | 2020-11-12 | 2020-11-12 | Diagnostyczny zestaw biomarkerów miRNA do diagnostyki raka jajnika, sposób diagnostyki in vitro raka jajnika, zastosowania takiego zestawu biomarkerów miRNA oraz zestaw testowy do diagnostyki in vitro raka jajnika |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240002949A1 (pl) |
| EP (1) | EP4244393A1 (pl) |
| AU (1) | AU2021378868A1 (pl) |
| CA (1) | CA3198479A1 (pl) |
| PL (1) | PL243444B1 (pl) |
| WO (1) | WO2022103287A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250174355A1 (en) * | 2022-07-04 | 2025-05-29 | Artificial Intelligence Expert Srl | Method and system for multi-cancer management in subject |
| GB2623570B (en) * | 2022-10-21 | 2025-07-23 | Wobble Genomics Ltd | Method and products for biomarker identification |
| CN117838868A (zh) * | 2024-03-04 | 2024-04-09 | 暨南大学 | miR-103-3p在ADSCs移植中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010098862A2 (en) * | 2009-02-24 | 2010-09-02 | Combimatrix Corporation | Method of using an oligonucleotide microarray to detect cancer from serum nucleic acid |
| EP2354246A1 (en) * | 2010-02-05 | 2011-08-10 | febit holding GmbH | miRNA in the diagnosis of ovarian cancer |
| US11214839B2 (en) * | 2017-01-09 | 2022-01-04 | Dana-Farber Cancer Institute, Inc. | Circulating microRNA signatures for ovarian cancer |
| KR102736612B1 (ko) * | 2017-04-28 | 2024-12-03 | 국립연구개발법인 고쿠리츠간켄큐센터 | 난소 종양의 검출을 위한 키트, 디바이스, 및 방법 |
| CN111826466B (zh) * | 2020-07-31 | 2021-06-29 | 南方医科大学深圳医院 | 乙型肝炎感染患者或携带者外泌体miRNA分子标志物组合及筛查试剂盒 |
-
2020
- 2020-11-11 US US18/252,634 patent/US20240002949A1/en active Pending
- 2020-11-12 PL PL435967A patent/PL243444B1/pl unknown
-
2021
- 2021-11-11 AU AU2021378868A patent/AU2021378868A1/en active Pending
- 2021-11-11 EP EP21840201.4A patent/EP4244393A1/en active Pending
- 2021-11-11 WO PCT/PL2021/050079 patent/WO2022103287A1/en not_active Ceased
- 2021-11-11 CA CA3198479A patent/CA3198479A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| PL243444B1 (pl) | 2023-08-28 |
| CA3198479A1 (en) | 2022-05-19 |
| AU2021378868A1 (en) | 2023-06-15 |
| EP4244393A1 (en) | 2023-09-20 |
| US20240002949A1 (en) | 2024-01-04 |
| AU2021378868A9 (en) | 2025-01-09 |
| WO2022103287A4 (en) | 2022-07-07 |
| WO2022103287A1 (en) | 2022-05-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3907509A3 (en) | Diagnosis of early stage pancreatic cancer | |
| GB201207297D0 (en) | Analytical methods and arrays for use in the same | |
| WO2014201516A3 (en) | Biomarker identification | |
| MX390772B (es) | Métodos para tratar cáncer y el uso de biomarcadores como predictor de sensibilidad clínica a terapias. | |
| CL2017001972A1 (es) | Biomarcadores para cáncer pancreático | |
| WO2015067969A3 (en) | Method, array and use thereof for determining pancreatic cancer | |
| NZ629074A (en) | Biomarkers for gastric cancer and uses thereof | |
| WO2012120288A3 (en) | Method, array and use for determining the presence of pancreatic cancer. | |
| EA201290311A1 (ru) | Факторы риска и прогнозирование инфаркта миокарда | |
| GB201316222D0 (en) | Biomarker panels diagnostic and test kits for ovarian cancer | |
| MX2019008911A (es) | Metodos, matrices y usos de estos. | |
| MX367046B (es) | Marcadores especificos de via para diagnosticar sindrome del intestino irritable. | |
| WO2015006489A8 (en) | Blood-based screen for detecting neurological diseases in primary care settings | |
| WO2016198833A3 (en) | Methods for analysing a urine sample | |
| MX2020002788A (es) | Biomarcadores de preeclampsia y sistemas y metodos relacionados. | |
| MX2016001719A (es) | Metodos y equipos para predecir el riesgo de tener una enfermedad o evento cardiovascular. | |
| BR112016013976A2 (pt) | método para determinar se um indivíduo é afetado por um câncer, método para discriminar entre câncer colorretal e pancreático dentre indivíduos que resultam ser positivos para o método, método para determinar o estágio de um câncer colorretal em um indivíduo afetado e uso de um kit de rt-pcr quantitativo para performar o método | |
| GB2509682A (en) | Biomarkers useful for detection of tyres, grades and stages of human breast cancer | |
| BR112018073214A2 (pt) | métodos para a previsão do risco de recorrência da fibrilação atrial, para o diagnóstico de fibrilação atrial em um indivíduo, para o monitoramento de uma terapia e para a classificação da fibrilação e utilizações do biomarcador | |
| WO2015189591A3 (en) | Method and arrays for use in diagnosing early breast cancer | |
| MX374601B (es) | Procedimientos y series para su uso en los mismos. | |
| GB201009798D0 (en) | Method,array and use thereof | |
| ZA202308936B (en) | Salivary biomarkers of brain injury | |
| BR112017011026A2 (pt) | métodos analíticos e arranjos para uso nos mesmos | |
| WO2018208122A8 (ko) | 담도 세포에서 메티오닐-타알엔에이 합성효소를 이용한 담도암 진단 방법 |